Aurobindo Pharma Share Price
18 Nov, 2026 3:55 PM (IST)
Aurobindo Pharma Performance
- Today's Low
- ₹1,789
- Today's High
- ₹1,817
- 52 Week Low
- ₹1,106
- 52 Week High
- ₹1,860
- Open Price₹1,794
- Previous Close₹1,794
- Volume1,221,857
- 50 DMA₹1,703.00
- 100 DMA₹1,640.00
- 200 DMA₹1,530.70
Aurobindo Pharma Chart
Investment Returns
- Over 1 Month + 7.76%
- Over 3 Month + 9.2%
- Over 6 Month + 19.71%
- Over 1 Year + 44.94%
Smart Investing Starts Here Start SIP with Aurobindo Pharma for Steady Growth!
Aurobindo Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 24.7
- PEG Ratio
- 1.1
- Market Cap Cr
- 104,329
- P/B Ratio
- 2.7
- Average True Range
- 42.1
- EPS
- 72.6
- Dividend Yield
- 0.4
- MACD Signal
- 40
- RSI
- 60.69
- MFI
- 66.41
Latest Stock News Updates
Submission of Postal Ballot Notice.
- BSE India
- 20 hours 9 minutes ago
Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company.
- BSE India
- 1 week ago
Submission of Earning Call Transcript for Q2FY27.
- BSE India
- 1 week ago
Aurobindo Pharma Financials
Aurobindo Pharma Technicals
EMA & SMA
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹1,753.80
- 50 Day
- ₹1,703.00
- 100 Day
- ₹1,640.00
- 200 Day
- ₹1,530.70
Resistance and Support
- R3 1,841.60
- R2 1,829.50
- R1 1,812.90
- S1 1,784.20
- S2 1,772.10
- S3 1,755.50
Aurobindo Pharma Corporate Actions - Bonus, Splits, Dividends
Aurobindo Pharma F&O
About Aurobindo Pharma
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. View More- NSE Symbol
- AUROPHARMA
- BSE Symbol
- 524804
- ISIN
- INE406A01037
Similar Stocks to Aurobindo Pharma
Popular Stocks
Aurobindo Pharma FAQs
Aurobindo Pharma share price is ₹1,796 As on 19 November, 2026 | 08:09
The Market Cap of Aurobindo Pharma is ₹104329.4 Cr As on 19 November, 2026 | 08:09
The P/E ratio of Aurobindo Pharma is 24.7 As on 19 November, 2026 | 08:09
The PB ratio of Aurobindo Pharma is 2.7 As on 19 November, 2026 | 08:09
The 52 week High & Low of Aurobindo Pharma is ₹1859.9/₹1106 respectively As on 19 November, 2026 | 08:09
Aurobindo Pharma has an operating revenue of Rs.24,010.31 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 30% is great. Many brokers and analysts have recommended 'Buy' on the stock.
Aurobindo Pharma Ltd. has declared 40 dividends since May 10, 2000.
The stock price CAGR of Aurobindo Pharma for 10 Years is 30%, 5 Years is 0%, 3 Years is -3%, 1 Year is -25%.
Aurobindo Pharma has an ROE of 24% which is exceptional.
Aurobindo Pharma has a reasonable debt to equity of 1%, which signals a healthy balance sheet.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.